Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-27 7:27 pm Purchase | 2023-09-29 | 13D | Estrella Immunopharma, Inc. ESLA | Eureka Therapeutics Inc. | 25,277,831 71.800% | 25,277,831 (New Position) | Filing History |
| 2023-03-10 4:04 pm Sale | 2023-02-28 | 13G | TradeUP Acquisition Corp. UPTD | Karpus Management Inc. | 0 0.000% | -863,249 (Position Closed) | Filing History |
| 2023-02-14 4:49 pm Sale | 2022-12-31 | 13G | TRADEUP ACQUIS CORP UNIT 1 COM UPTDU | ATW SPAC MANAGEMENT LLC | 0 0.000% | -390,000 (Position Closed) | Filing History |
| 2023-02-14 4:31 pm Sale | 2022-12-31 | 13G | TradeUP Acquisition Corp. UPTD | Karpus Management Inc. | 863,249 14.750% | -3,002 (-0.35%) | Filing History |
| 2023-01-31 12:33 pm Sale | 2022-12-31 | 13G | TradeUP Acquisition Corp. UPTD | BOOTHBAY FUND MANAGEMENT LLC | 0 0.000% | -390,000 (Position Closed) | Filing History |
| 2022-03-17 4:50 pm Unchanged | 2022-03-17 | 13G | Estrella Immunopharma, Inc. ESLA | Li Jianwei | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:27 pm Unchanged | 2022-02-14 | 13G | Estrella Immunopharma, Inc. ESLA | Karpus Management Inc. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 07:04 am Unchanged | 2022-02-14 | 13G | Estrella Immunopharma, Inc. ESLA | ATW SPAC MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-04 4:18 pm Unchanged | 2022-02-04 | 13G | Estrella Immunopharma, Inc. ESLA | BOOTHBAY FUND MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-02 2:21 pm Unchanged | 2022-02-02 | 13G | Estrella Immunopharma, Inc. ESLA | Space Summit Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-10-08 5:13 pm Unchanged | 2021-10-08 | 13G | Estrella Immunopharma, Inc. ESLA | K2 PRINCIPAL FUND L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-10-08 4:27 pm Unchanged | 2021-10-08 | 13G | Estrella Immunopharma, Inc. ESLA | Karpus Management Inc. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-07-27 08:35 am Unchanged | 2021-07-27 | 13G | Estrella Immunopharma, Inc. ESLA | K2 PRINCIPAL FUND L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-07-22 5:19 pm Unchanged | 2021-07-22 | 13G | Estrella Immunopharma, Inc. ESLA | Space Summit Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-07-22 4:08 pm Unchanged | 2021-07-22 | 13G | Estrella Immunopharma, Inc. ESLA | TradeUP Acquisition Sponsor LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-07-19 5:56 pm Unchanged | 2021-07-19 | 13G | Estrella Immunopharma, Inc. ESLA | K2 PRINCIPAL FUND L.P. | 0 0.000% | 0 (Unchanged) | Filing |